Cardiac Safety Evaluation of P03277
NCT03657264
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
P03277 0.1 mmol/kg
DRUG:
Moxifloxacin 400mg
DRUG:
NaCl 0.9%
DRUG:
P03277 0.3 mmol/kg
Sponsor
Guerbet